ERIC REUTER: Open Payments
NPI 1407814551 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 31 payments from 9 companies in 2025. Trend: 2023 $801 · 2024 $1,113 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $157 |
| Merck Sharp & Dohme LLC | 5 | $107 |
| SK Life Science, Inc. | 3 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| ABBVIE INC. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: ELIQUIS, ZERBAXA, XIFAXAN, LEQVIO, DALVANCE, UBRELVY, LifeVest, TEFLARO.
Industry payments across NC — which companies pay providers there.
